Literature DB >> 31922498

SURGICAL OUTCOMES OF 25-GAUGE PARS PLANA VITRECTOMY USING AIR AS AN INTERNAL TAMPONADE FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT.

Yunyun Li1, Ning Cheung2, Liyun Jia1, Hui Zhang1, Ningpu Liu1.   

Abstract

PURPOSE: To report surgical outcomes of 25-gauge pars plana vitrectomy using air as an internal tamponade for patients with primary rhegmatogenous retinal detachment (RRD).
METHODS: A retrospective clinical study of 59 eyes of 59 consecutive patients presented with primary RRD at the Beijing Tongren Eye Center in China. From August 2016 to May 2018, medical records of the patients who underwent 25-gauge pars plana vitrectomy with air tamponade for RRD were reviewed. The main outcome measures were primary and final anatomical success (retinal re-attachment) rates, and postoperative complications.
RESULTS: Of the 59 patients, aged 54.47 ± 11.81 years, 31 (52.5%) were men. Vitrectomy was performed 3 to 40 (averaged 16.98 ± 10.17) days after the onset of symptoms, and the mean follow-up period was 12.90 ± 5.92 months (ranging 6.07-26.10 months). Forty-two eyes (71.2%) had RRD with retinal breaks in the superior half of the retina, and the mean number of retinal breaks was 1.75 ± 0.94. Three eyes (5.1%) had RRD with giant retinal tears. Of the 59 eyes, 35 (59.3%) had RRD with inferior quadrants involved. Proliferative vitreoretinopathy (PVR) gradings were C1 in 2 (3.4%) eyes and B or below in 57 (96.6%) eyes. The primary and final anatomical success rates were 94.9% (56/59) and 98.3% (58/59), respectively. Of the three eyes which developed re-detachment of the retina, one eye had postoperative progression of PVR and two eyes were RRD associated with macular hole in high myopia. Postoperative complications included 5 eyes (8.5%) with serous choroidal detachment within 3 days after surgery and 4 eyes (6.8%) with macular epiretinal membrane formation 1 to 8 months after surgery. Secondary cataract surgery was performed in 13 of the 53 phakic eyes (24.5%) during follow-up.
CONCLUSION: Small-gauge pars plana vitrectomy with air tamponade may be effective in treating selected cases of relatively simple primary RRD. Additional studies are needed to verify the efficacy of this surgical approach for more complicated cases such as those with giant retinal tears.

Entities:  

Year:  2020        PMID: 31922498     DOI: 10.1097/IAE.0000000000002744

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Vitrectomy with air tamponade for surgical repair of rhegmatogenous retinal detachment by eye position guided fluid-air exchange.

Authors:  Yu-Hong Cheng; Hua Wang; Bo Li; Meng Ji; Qiang Shi; Yun Qi; Ya-Guang Hu; An-Ming Xie; Cheng Pei
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

2.  Retinal Tamponades: Current Uses and Future Technologies.

Authors:  Avnish Deobhakta; Richard Rosen
Journal:  Curr Ophthalmol Rep       Date:  2020-07-04

3.  Environmental effect of air versus gas tamponade in the management of rhegmatogenous retinal detachment VR surgery: A multicentre study of 3,239 patients.

Authors:  George Moussa; Walter Andreatta; Soon Wai Ch'ng; Hadi Ziaei; Assad Jalil; Niall Patton; Tsveta Ivanova; Kim Son Lett; Dong Young Park
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

4.  Outcomes of 25-gauge pars plana vitrectomy alone with air tamponade for the management of rhegmatogenous retinal detachment with inferior breaks.

Authors:  Yongping Tang; Bo Lin; Jing Chen; Daosen Chen; Ronghan Wu
Journal:  BMC Ophthalmol       Date:  2022-05-12       Impact factor: 2.209

5.  Clinical characteristics of primary pars plana vitrectomy combined with air filling for rhegmatogenous retinal detachment.

Authors:  Changzhong Xu; Jianhua Wu; Yanzi Li; Rui Zhang; Chao Feng
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

6.  Air Tamponade for Rhegmatogenous Retinal Detachment With Inferior Breaks After 25-Gauge Pars Plana Vitrectomy: Technique and Outcome.

Authors:  Peiyang Shen; Xiangbin Kong; Lijun Zhou; Peng Su; Xiaohe Lu; Mingguang He
Journal:  Front Med (Lausanne)       Date:  2022-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.